• 1
    Centers for Disease Control and Prevention. Inactivated Japanese encephalitis virus vaccine: recommendation of the advisory committee on immunization practices (ACIP). MMWR Morb Mortal Wkly Rep 1993; 42:(RR-1).
  • 2
    Buhl MR, Lindquist L. Japanese Encephalitis in Travelers: Review of Cases and Seasonal Risk. J Travel Med 2009; 16:217219.
  • 3
    Lehtinen VA, Huhtamo E, Siikamaki H, Vapalahti O. Japanese encephalitis in a Finnish traveler on a two-week holiday in Thailand. J Clin Virol 2008; 43:9395.
  • 4
    Huber D. 9-year-old faces hard recovery after catching rare virus in Asia. Seattle, WA: The Olympian, 2008.
  • 5
    Caramello P, Canta F, Balbiano R, et al. A case of imported JE acquired during short travel in Vietnam. Are current recommendations about vaccination broader? J Travel Med 2007; 14:346348.
  • 6
    Wittesjo B, Eitrem R, Niklasson B, et al. Japanese encephalitis after a 10-day holiday in Bali. Lancet 1995; 345:856857.
  • 7
    Macdonald WB, Tink AR, Ouvrier RA, et al. Japanese encephalitis after a two-week holiday in Bali. Med J Aust 1989; 150:334336, 339.
  • 8
    Shlim DR, Solomon T. Japanese encephalitis vaccine for travelers: exploring the limits of risk. Clin Infect Dis 2002; 35:183188.
  • 9
    Japan Ministry of Health Law. About the forbearance of positive encouragement of the encephalitis B vaccination. 2005. Available at: (Accessed 2008 Dec 1)
  • 10
    Tauber E, Kollaritsch H, Von Sonnenburg F, et al. Randomized, double-blind, placebo-controlled phase 3 trial of the safety and tolerability of ic51, an inactivated Japanese encephalitis vaccine. J Infect Dis 2008; 198:493499.
  • 11
    Tauber E, Kollaritsch H, Korinek M, et al. Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial. Lancet 2007; 370:18471853.
  • 12
    Schuller E, Jilma B, Voicu V, et al. Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51 Six and 12 month results of a multicenter follow-up phase 3 study. Vaccine 2008; 26:43824386.
  • 13
    Konishi E, Suzuki T. Ratios of subclinical to clinical Japanese encephalitis (JE) virus infections in vaccinated populations: evaluation of an inactivated JE vaccine by comparing the ratios with those in unvaccinated populations. Vaccine 2002; 21:98107.
  • 14
    Tsai T, Yu Y. Japanese encephalitis vaccines. In: PlotkinS, OrensteinW, eds. Vaccines. 3rd Ed. Philadelphia, PA: WB Saunders, 1999: 672710.
  • 15
    Ding D, Hong Z, Zhao SJ, et al. Long-term disability from acute childhood Japanese encephalitis in Shanghai, China. Am J Trop Med Hyg 2007; 77:528533.
  • 16
    Liu W, Clemens JD, Kari K, Xu ZY. Cost-effectiveness of Japanese encephalitis (JE) immunization in Bali, Indonesia. Vaccine 2008; 26:44564460.
  • 17
    Ooi MH, Lewthwaite P, Lai BF, et al. The epidemiology, clinical features, and long-term prognosis of Japanese encephalitis in central Sarawak, Malaysia, 1997-2005. Clin Infect Dis 2008; 47:458468.
  • 18
    Pieper SJ, Jr, Kurland LT. Sequelae of Japanese B and mumps encephalitis: recent follow-up of patients affected in 1947-1948 epidemic on Guam. Am J Trop Med Hyg 1958; 7:481490.
  • 19
    Paul WS, Moore PS, Karabatsos N, et al. Outbreak of Japanese encephalitis on the island of Saipan, 1990. J Infect Dis 1993; 167:10531058.
  • 20
    Hanna JN, Ritchie SA, Phillips DA, et al. An outbreak of Japanese encephalitis in the Torres Strait, Australia, 1995. Med J Aust 1996; 165:256260.
  • 21
    Hammon WM, Tigertt WD, Sather GE, et al. Epidemiologic studies of concurrent virgin epidemics of Japanese B encephalitis and of mumps on Guam, 1947-1948, with subsequent observations including dengue, through 1957. Am J Trop Med Hyg 1958; 7:441467.
  • 22
    Endy TP, Nisalak A. Japanese encephalitis virus: ecology and epidemiology. Curr Top Microbiol Immunol 2002; 267:1148.
  • 23
    Igarashi A. Control of Japanese encephalitis in Japan: immunization of humans and animals, and vector control. Curr Top Microbiol Immunol 2002; 267:139152.
  • 24
    Rosen L. The natural history of Japanese encephalitis virus. Annu Rev Microbiol 1986; 40:395414.
  • 25
    Burke DS, Leake CJ. Japanese encephalitis. In: MonathTP, ed. The arboviruses: epidemiology and ecology. Boca Raton, FL: CRC Press, 1988: 6392.
  • 26
    Oya A. Japanese encephalitis vaccine. Acta Paediatr Jpn 1988; 30:175184.
  • 27
    Wu YC, Huang YS, Chien LJ, et al. The epidemiology of Japanese encephalitis on Taiwan during 1966-1997. Am J Trop Med Hyg 1999; 61:7884.
  • 28
    Sohn YM. Japanese encephalitis immunization in South Korea: past, present, and future. Emerg Infect Dis 2000; 6:1724.
  • 29
    Li YX, Yin ZD, Yang JF, et al. [Epidemic situation analysis of Japanese encephalitis in 2005.]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2006; 20:216218.
  • 30
    Zhou B, Jia L, Xu X. [A large-scale study on the safety and epidemiological efficacy of Japanese encephalitis (JE) live vaccine (SA14-14-2) in the JE endemic areas]. Zhonghua Liu Xing Bing Xue Za Zhi 1999; 20:3841.
  • 31
    Tsai TF. New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, 13–15 October 1998. Vaccine 2000; 18(Suppl 2):125.
  • 32
    World Tourism Organization (UNWTO). Tourism 2020 vision. 2007. Available at: http://unwtoorg/facts/eng/visionhtm. (Accessed 2008 Dec 1)
  • 33
    World Tourism Organization (UNWTO). UNWTO World Tourism Barometer. 2008; 63151.
  • 34
    World Tourism Organization (UNWTO). Tourism Market Trends 2005: Asia and Pacific. Madrid, Spain: World Tourism Organization. 2006.
  • 35
    Davis X, Marano N, Von Sonnenburg F, et al. Disease outcomes among travelers with different travel purposes: findings from GeoSentinel. 2nd Northern European Conference on Travel Medicine, Helsinki, Finland, 2008. (Abstr F6F4)
  • 36
    Kari K, Liu W, Gautama K, et al. A hospital-based surveillance for Japanese encephalitis in Bali, Indonesia. BMC Med 2006; 4:8.
  • 37
    Berg SW, Mitchell BS, Hanson RK, et al. Systemic reactions in U.S. Marine Corps personnel who received Japanese encephalitis vaccine. Clin Infect Dis 1997; 24:265266.
  • 38
    Hoke CH, Nisalak A, Sangawhipa N, et al. Protection against Japanese encephalitis by inactivated vaccines. N Engl J Med 1988; 319:608614.
  • 39
    Benenson MW, Top FH, Jr, Gresso W, et al. The virulence to man of Japanese encephalitis virus in Thailand. Am J Trop Med Hyg 1975; 24:974980.
  • 40
    Grossman RA, Edelman R, Chiewanich P, et al. Study of Japanese encephalitis virus in Chiangmai valley, Thailand. II. Human clinical infections. Am J Epidemiol 1973; 98:121132.
  • 41
    Hsu TC, Chow LP, Wei HY, et al. A controlled field trial for an evaluation of effectiveness of mouse-brain Japanese encephalitis vaccine. Taiwan Yi Xue Hui Za Zhi 1971; 70:5562.
  • 42
    Okuno T, Tseng PT, Hsu ST, et al. Japanese encephalitis surveillance in China (Province of Taiwan) during 1968-1971. II. Age-specific incidence in connection with Japanese encephalitis vaccination program. Jpn J Med Sci Biol 1975; 28:255267.
  • 43
    Rojanasuphot S, Tsai TF. Regional workshop on control strategies for Japanese encephalitis. Southeast Asian J Trop Med Public Health 1995; 26:159.
  • 44
    Wong SC, Ooi MH, Abdullah AR, et al. A decade of Japanese encephalitis surveillance in Sarawak, Malaysia: 1997-2006. Trop Med Int Health 2008; 13:5255.
  • 45
    Solomon T, Thao TT, Lewthwaite P, et al. A cohort study to assess the new WHO Japanese encephalitis surveillance standards. Bull World Health Organ 2008; 86:178186.
  • 46
    Yu Y. Japanese encephalitis in China. Southeast Asian J Trop Med Public Health 1995; 26:1722.
  • 47
    Kanojia PC, Shetty PS, Geevarghese G. A long-term study on vector abundance & seasonal prevalence in relation to the occurrence of Japanese encephalitis in Gorakhpur district, Uttar Pradesh. Indian J Med Res 2003; 117:104110.
  • 48
    Pogodina VV, Bochkova NG, Leshchinskaia EV, Levina LS. [Japanese encephalitis in citizens of Russia who travel abroad]. Vopr Virusol 1996; 41:811.
  • 49
    Watt G, Jongsakul K. Acute undifferentiated fever caused by infection with Japanese encephalitis virus. Am J Trop Med Hyg 2003; 68:704706.
  • 50
    Cardosa MJ, Hooi TP, Kaur P. Japanese encephalitis virus is an important cause of encephalitis among children in Penang. Southeast Asian J Trop Med Public Health 1995; 26:272275.
  • 51
    Chung CC, Lee SS, Chen YS, et al. Acute flaccid paralysis as an unusual presenting symptom of Japanese encephalitis: a case report and review of the literature. Infection 2007; 35:3032.
  • 52
    Hosokawa T, Nakajima H, Takasaki T, et al. [Case report of aseptic meningitis due to Japanese encephalitis virus]. Rinsho Shinkeigaku 2007; 47:109111.
  • 53
    Kabilan L, Ramesh S, Srinivasan S, et al. Hospital- and laboratory-based investigations of hospitalized children with central nervous system-related symptoms to assess Japanese encephalitis virus etiology in Cuddalore District, Tamil Nadu, India. J Clin Microbiol 2004; 42:28132815.
  • 54
    Chhour YM, Ruble G, Hong R, et al. Hospital-based diagnosis of hemorrhagic fever, encephalitis, and hepatitis in Cambodian children. Emerg Infect Dis 2002; 8:485489.
  • 55
    Natividad FF, Daroy ML, Alonzo MT, et al. Use of IgM-capture ELISA for confirmation of Japanese encephalitis infections in the Philippines. Southeast Asian J Trop Med Public Health 2006; 37(Suppl 3):136139.
  • 56
    Arai S, Matsunaga Y, Takasaki T, et al. Japanese encephalitis: surveillance and elimination effort in Japan from 1982 to 2004. Jpn J Infect Dis 2008; 61:333338.
  • 57
    Infectious Disease Surveillance Center. Department of Health J. Japanese encephalitis HI antibody prevalence of swine in Japan. 2007. (Accessed 2008 Dec 1)
  • 58
    Konishi E, Shoda M, Kondo T. Analysis of yearly changes in levels of antibodies to Japanese encephalitis virus nonstructural 1 protein in racehorses in central Japan shows high levels of natural virus activity still exist. Vaccine 2006; 24:516524.
  • 59
    Nidaira M, Taira K, Itokazu K, et al. Survey of the antibody against Japanese encephalitis virus in Ryukyu wild boars (Sus scrofa riukiuanus) in Okinawa, Japan. Jpn J Infect Dis 2007; 60:309311.
  • 60
    See E, Tan HC, Wang D, et al. Presence of hemagglutination inhibition and neutralization antibodies to Japanese encephalitis virus in wild pigs on an offshore island in Singapore. Acta Trop 2002; 81:233236.
  • 61
    Hamano M, Lim CK, Takagi H, et al. Detection of antibodies to Japanese encephalitis virus in the wild boars in Hiroshima prefecture, Japan. Epidemiol Infect 2007; 135:974977.
  • 62
    Yang DK, Kweon CH, Kim BH, et al. The seroprevalence of Japanese encephalitis virus in goats raised in Korea. J Vet Sci 2007; 8:197199.
  • 63
    Turell MJ, Mores CN, Dohm DJ, et al. Laboratory transmission of Japanese encephalitis, West Nile, and Getah viruses by mosquitoes (Diptera: Culicidae) collected near Camp Greaves, Gyeonggi Province, Republic of Korea 2003. J Med Entomol 2006; 43:10761081.
  • 64
    Matsunaga T, Shoda M, Konishi E. Japanese encephalitis viral infection remains common in Japan. Pediatr Infect Dis J 2008; 27:769770.
  • 65
    Konishi E, Shoda M, Yamamoto S, et al. Natural infection with Japanese encephalitis virus among inhabitants of Japan: a nationwide survey of antibodies against nonstructural 1 protein. Vaccine 2006; 24:30543056.
  • 66
    Gingrich JB, Nisalak A, Latendresse JR, et al. A longitudinal study of Japanese encephalitis in suburban Bangkok, Thailand. Southeast Asian J Trop Med Public Health 1987; 18:558566.
  • 67
    Gingrich JB, Nisalak A, Latendresse JR, et al. Japanese encephalitis virus in Bangkok: factors influencing vector infections in three suburban communities. J Med Entomol 1992; 29:436444.
  • 68
    Oya A, Kurane I. Japanese encephalitis for a reference to international travelers. J Travel Med 2007; 14:259268.
  • 69
    Ritchie SA, Rochester W. Wind-blown mosquitoes and introduction of Japanese encephalitis into Australia. Emerg Infect Dis 2001; 7:900903.
  • 70
    Nga PT, Del Carmen PM, Cuong VD, et al. Shift in Japanese encephalitis virus (JEV) genotype circulating in northern Vietnam: implications for frequent introductions of JEV from Southeast Asia to East Asia. J Gen Virol 2004; 85:16251631.
  • 71
    Ming JG, Jin H, Riley JR, et al. Autumn southward ‘return’ migration of the mosquito Culex tritaeniorhynchus in China. Med Vet Entomol 1993; 7:323327.
  • 72
    Nidaira M, Taira K, Onodera I, et al. Detection of Japanese encephalitis virus antibody in a pig on Yonaguni Island, where all pigs were slaughtered in 1997. Jpn J Infect Dis 2007; 60:7071.
  • 73
    Kanojia PC, Geevarghese G. First report on high-degree endophilism in Culex tritaeniorhynchus (Diptera: Culicidae) in an area endemic for Japanese encephalitis. J Med Entomol 2004; 41:994996.
  • 74
    Tsai TF. Flaviviruses. In: MandellG, BennettJ, DolinR, eds. Principles and practice of infectious diseases. 5th Ed. Philadelphia, PA: Churchill-Livingston, 2000: 17141736.
  • 75
    Ayukawa R, Fujimoto H, Ayabe M, et al. An unexpected outbreak of Japanese encephalitis in the Chugoku district of Japan, 2002. Jpn J Infect Dis 2004; 57:6366.
  • 76
    Xu ZQ, Fu SH, Zhang YP, et al. [Laboratory testing of sepcimens from patients with viral encephalitis from some regions of China]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2008; 22:98100.
  • 77
    Zhang DL, Ma LB, Fu SH, et al. Clinical characteristics and laboratory assay of adult Japanese encephalitis patients in an outbreak in Yuncheng, Shanxi Province, 2006]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2008; 22:9597.
  • 78
    Monath TP, Tsai TF. Flaviviruses. In: RichmanD, WhitleyR, HaydenF, eds. Clinical virology. 2nd Ed. Washington, DC: American Society of Microbiology, 2002: 10971092.
  • 79
    Tsai TF, Canfield MA, Reed CM, et al. Epidemiological aspects of a St. Louis encephalitis outbreak in Harris County, Texas, 1986. J Infect Dis 1988; 157:351356.
  • 80
    Das S, Basu A. Japanese encephalitis virus infects neural progenitor cells and decreases their proliferation. J Neurochem 2008; 106:16241636.
  • 81
    Khairallah M, Yahia SB, Letaief M, et al. A prospective evaluation of factors associated with chorioretinitis in patients with West Nile virus infection. Ocul Immunol Inflamm 2007; 15:435439.
  • 82
    Brown JA, Factor DL, Tkachenko N, et al. West Nile viremic blood donors and risk factors for subsequent West Nile fever. Vector Borne Zoonotic Dis 2007; 7:479488.
  • 83
    Murray K, Baraniuk S, Resnick M, et al. Risk factors for encephalitis and death from West Nile virus infection. Epidemiol Infect 2006; 134:13251332.
  • 84
    Jean CM, Honarmand S, Louie JK, Glaser CA. Risk factors for West Nile virus neuroinvasive disease, California, 2005. Emerg Infect Dis 2007; 13:19181920.
  • 85
    Broun GO. Relationship of hypertensive vascular disease to mortality in cases of St. Louis encephalitis. Med Bull St Louis Univ 1952; 4:3237.
  • 86
    Kumar D, Prasad GV, Zaltzman J, et al. Community-acquired West Nile virus infection in solid-organ transplant recipients. Transplantation 2004; 77:399402.
  • 87
    McElhaney JE, Herre JM, Lawson ML, et al. Effect of congestive heart failure on humoral and ex vivo cellular immune responses to influenza vaccination in older adults. Vaccine 2004; 22:681688.
  • 88
    Bond JO, Hammon WM. Epidemiologic studies of possible cross protection between dengue and St. Louis encephalitis arboviruses in Florida. Am J Epidemiol 1970; 92:321329.
  • 89
    Edelman R, Schneider RJ, Chieowanich P, et al. The effect of dengue virus infection on the clinical sequelae of Japanese encephalitis: a one year follow-up study in Thailand. Southeast Asian J Trop Med Public Health 1975; 6:308315.
  • 90
    Libraty DH, Nisalak A, Endy TP, et al. Clinical and immunological risk factors for severe disease in Japanese encephalitis. Trans R Soc Trop Med Hyg 2002; 96:173178.
  • 91
    Chan-Tack KM, Forrest G. West Nile virus meningoencephalitis and acute flaccid paralysis after infliximab treatment. J Rheumatol 2006; 33:191192.
  • 92
    Liu YF, Teng CL, Liu K. Cerebral cysticercosis as a factor aggravating Japanese B encephalitis. Chin Med J 1957; 75:10101017.
  • 93
    Handique SK, Das RR, Saharia B, et al. Coinfection of Japanese encephalitis with neurocysticercosis: an imaging study. AJNR Am J Neuroradiol 2008; 29:170175.
  • 94
    Singh P, Kalra N, Ratho RK, et al. Coexistent neurocysticercosis and Japanese B encephalitis: MR imaging correlation. AJNR Am J Neuroradiol 2001; 22:11311136.
  • 95
    Das SK, Nityanand S, Sood K, et al. Japanese B encephalitis with neurocysticercosis. J Assoc Physicians India 1991; 39:643644.
  • 96
    Desai A, Shankar SK, Jayakumar PN, et al. Co-existence of cerebral cysticercosis with Japanese encephalitis: a prognostic modulator. Epidemiol Infect 1997; 118:165171.
  • 97
    Azad R, Gupta RK, Kumar S, et al. Is neurocysticercosis a risk factor in coexistent intracranial disease? An MRI based study. J Neurol Neurosurg Psychiatry 2003; 74:359361.
  • 98
    Hayashi K, Arita T. Experimental double infection of Japanese encephalitis virus and herpes simplex virus in mouse brain. Jpn J Exp Med 1977; 47:913.
  • 99
    Lange DG, Sedmak J. Japanese encephalitis virus (JEV): potentiation of lethality in mice by microwave radiation. Bioelectromagnetics 1991; 12:335348.
  • 100
    Gutierrez K, Abzug MJ. Vaccine-associated poliovirus meningitis in children with ventriculoperitoneal shunts. J Pediatr 1990; 117:424427.
  • 101
    Wei BP, Robins-Browne RM, Shepherd RK, et al. Can we prevent cochlear implant recipients from developing pneumococcal meningitis? Clin Infect Dis 2008; 46:e1e7.
  • 102
    Pneumococcal vaccination for cochlear implant candidates and recipients: updated recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 2003; 52:739740.
  • 103
    Mathur A, Tandon HO, Mathur KR, et al. Japanese encephalitis virus infection during pregnancy. Indian J Med Res 1985; 81:912.
  • 104
    Chaturvedi UC, Mathur A, Chandra A, et al. Transplacental infection with Japanese encephalitis virus. J Infect Dis 1980; 141:712715.
  • 105
    Alpert SG, Fergerson J, Noel LP. Intrauterine West Nile virus: ocular and systemic findings. Am J Ophthalmol 2003; 136:733735.
  • 106
    Interim guidelines for the evaluation of infants born to mothers infected with West Nile virus during pregnancy. MMWR Morb Mortal Wkly Rep 2004; 53:154157.
  • 107
    O’Leary DR, Kuhn S, Kniss KL, et al. Birth outcomes following West Nile Virus infection of pregnant women in the United States: 2003-2004. Pediatrics 2006; 117:e537e545.
  • 108
    Paisley JE, Hinckley AF, O’Leary DR, et al. West Nile virus infection among pregnant women in a northern Colorado community, 2003 to 2004. Pediatrics 2006; 117:814820.
  • 109
    Intrauterine West Nile virus infection—New York, 2002. MMWR Morb Mortal Wkly Rep 2002; 51:11351136.
  • 110
    Tsai TF. Congenital arboviral infections: something new, something old. Pediatrics 2006; 117:936939.
  • 111
    Lim JK, Louie CY, Glaser C, et al. Genetic deficiency of chemokine receptor CCR5 is a strong risk factor for symptomatic West Nile virus infection: a meta-analysis of 4 cohorts in the US epidemic. J Infect Dis 2008; 197:262265.
  • 112
    Lim JK, Glass WG, McDermott DH, Murphy PM. CCR5: no longer a “good for nothing” gene—chemokine control of West Nile virus infection. Trends Immunol 2006; 27:308312.
  • 113
    Diamond MS, Klein RS. A genetic basis for human susceptibility to West Nile virus. Trends Microbiol 2006; 14:287289.
  • 114
    Ferenczi E, Ban E, Abraham A, et al. Severe tick-borne encephalitis in a patient previously infected by West Nile virus. Scand J Infect Dis 2008; 40:759761.
  • 115
    Kindberg E, Mickiene A, Ax C, et al. A deletion in the chemokine receptor 5 (CCR5) gene is associated with tickborne encephalitis. J Infect Dis 2008; 197:266269.
  • 116
    Offit PA, Peter G. The meningococcal vaccine—public policy and individual choices. N Engl J Med 2003; 349:23532356.
  • 117
    Plesner AM. Allergic reactions to Japanese encephalitis vaccine. Immunol Allergy Clin North Am 2003; 23:665697.
  • 118
    Andersen MM, Ronne T. Side-effects with Japanese encephalitis vaccine. Lancet 1991; 337:1044.
  • 119
    Plesner A, Ronne T, Wachmann H. Case-control study of allergic reactions to Japanese encephalitis vaccine. Vaccine 2000; 18:18301836.
  • 120
    Plesner AM, Ronne T. Allergic mucocutaneous reactions to Japanese encephalitis vaccine. Vaccine 1997; 15:12391243.
  • 121
    Sakaguchi M, Nakashima K, Takahashi H, et al. Anaphylaxis to Japanese encephalitis vaccine. Allergy 2001; 56:804805.
  • 122
    Sakaguchi M, Miyazawa H, Inouye S. Specific IgE and IgG to gelatin in children with systemic cutaneous reactions to Japanese encephalitis vaccines. Allergy 2001; 56:536539.
  • 123
    Sakaguchi M, Inouye S. Two patterns of systemic immediate-type reactions to Japanese encephalitis vaccines. Vaccine 1998; 16:6869.
  • 124
    Sakaguchi M, Yoshida M, Kuroda W, et al. Systemic immediate-type reactions to gelatin included in Japanese encephalitis vaccines. Vaccine 1997; 15:121122.
  • 125
    Plesner AM, Arlien-Soborg P, Herning M. Neurological complications to vaccination against Japanese encephalitis. Eur J Neurol 1998; 5:479485.
  • 126
    Takahashi H, Pool V, Tsai1 TF, Chen RT. Adverse events after Japanese encephalitis vaccination: review of post-marketing surveillance data from Japan and the United States. The VAERS Working Group. Vaccine 2000; 18:29632969.
  • 127
    Nakayama T, Onoda K. Vaccine adverse events reported in post-marketing study of the Kitasato Institute from 1994 to 2004. Vaccine 2007; 25:570576.
  • 128
    Centers for Disease Control and Prevention. Announcement for healthcare professionals: Japanese Encephalitis Vaccine Availability. 2008. Available at: (Accessed 2008 Dec 1)
  • 129
    Japanese encephalitis in a U.S. traveler returning from Thailand, 2004. MMWR Morb Mortal Wkly Rep 2005; 54:123125.
  • 130
    Deutsche Gesellschaft für Tropenmedizin und Internationale Gesundheit. Recommendations on travel vaccines. 2008. Available at: (Accessed 2008 Dec 1)
  • 131
    Institut de Veille Sanitaire. Health recommendations for travelers. 2007. Available at: (Accessed 2008 Dec 1)
  • 132
    National Travel Health Network and Centre. Travel health information sheets—Japanese encephalitis. 2007. Available at: (Accessed 2008 Dec 1)
  • 133
    Lehner C, Eder G, Formica A, et al. Safety and immunogenicity of concomitant vaccination with IC51 and Hepatitis A vaccine in healthy subjects. A single-blind randomized controlled phase 3 study. Abstracts of the 56th American Society of Tropical Medicine and Hygiene Annual Meeting 2007. (Abstr 122)